Disease Ibd Equipment & Supplies In Rwanda
35 equipment items found
Manufactured by:Vedanta Biosciences, Inc based inCambridge, MASSACHUSETTS (USA)
VE202 is an orally administered rationally-defined bacterial consortium candidate being developed for the potential treatment of inflammatory bowel disease (IBD). VE202 consists of clonal human commensal bacteria strains selected for their ability to impact the number and activity of regulatory T cells in the gut mucosa and manufactured under cGMP ...
Manufactured by:Lumen Bioscience, Inc. based inSeattle, WASHINGTON (USA)
Inflammatory bowel disease (IBD) is a systemic autoimmune disease, but it has an obvious nexus with the gastrointestinal tract. The two main sub-varieties—Crohn’s disease and ulcerative colitis—have many available treatments on the market today, but it remains a major unmet medical need: current treatments are costly, require inconvenient injection delivery, and come with severe ...
Manufactured by:Bio-Me based inOslo, NORWAY
Our latest ready-to-use microbiome analysis solution. It consists of close to 100 unique assays for specific bacterial and fungal targets, including two controls. Targets were selected after extensive literature and database research on their abundance and frequency in the human gut, and on their relation to gut health. Our scientists are constantly improving PMP™ Broad Panel. Our aim is to ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
PENTASA® (mesalazine) is Ferring’s product used for the treatment and long-term management of inflammatory bowel diseases (IBD) (Ulcerative colitis and Crohn’s ...
Manufactured by:Enterome based inParis, FRANCE
Sibofimloc is a first-in-class, orally administered small molecule that is specifically designed to reduce the inflammatory cascade underlying Crohn’s disease and remain gut-restricted, to minimize absorption into the bloodstream. ...
Manufactured by:Yeasen Biotechnology (Shanghai) Co.,Ltd. based inShanghai, CHINA
Dextran sulfate sodium salt (DSS) is a polyanionic derivative of dextran produced by esterification of Dextran with chlorosulphonic acid. The sulfur content is approximately 17% which corresponds to an average of 1.9 sulfate groups per glucosyl residue of the dextran molecule. DSS has several characteristics: 1) polyanionic complex, soluble in water, forming a colorless aqueous solution; 2) high ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
BiomX develops phage cocktails (or combinations) that target and kill specific pathogenic bacteria. Our phage cocktails, which are optimized through algorithms and experimental validation (in-vitro and in-vivo), contain multiple natural and/or engineered phage. The phage are selected to have complementary functions such as wide target bacterial host range and the ability to avoid the development ...
Manufactured by:Enterome based inParis, FRANCE
EB1010 is an orally administered, GI-selective next generation IL-10 inducer designed to induce high local secretion of IL-10 for the treatment of Inflammatory Bowel Disease (IBD) and food allergy. EB1010 is a peptide that modulates the immune system by closely mimicking effects of a specific class of hormones. IL-10 deficiency is central to auto-immune, inflammatory and allergic diseases and a ...
Manufactured by:DiagNodus Ltd. based inCambridge, UNITED KINGDOM
DiagNodus has designed and patented methods for non-invasive collection and analysis of samples indicative of the state of the human bowel. The technology is based upon disease biomarker detection. The approach addresses a range of diagnostic, screening and monitoring applications within the field of colorectal disease, in particular targeting inflammatory bowel disease (IBD) and colorectal ...
by:Genova Diagnostics based inAsheville,, NORTH CAROLINA (USA)
An FDA-Cleared Gastrointestinal Test to Distinguish IBS from IBD. The Calprotectin gastrointestinal test effectively distinguishes Irritable Bowel Syndrome (IBS) from Inflammatory Bowel Disease (IBD). IBS and IBD often cause similar symptoms of abdominal pain, cramping, and chronic diarrhea, making an accurate diagnosis difficult. Calprotectin reliably differentiates IBS from IBD using a ...
Manufactured by:BiomX based inNess Ziona, ISRAEL
BX003 is an orally administered phage cocktail targeting a bacterial target present in the gut of IBD and PSC patients and thought to be associated with the onset or exacerbation of these diseases. Although different organs are affected in IBD and PSC (gut in IBD and liver in PSC) the two diseases are thought to be related since approximately 70% of PSC patients also suffer from IBD. Results from ...
Manufactured by:America Diagnostics, Inc. based inSan Diego, CA 92126 USA, CALIFORNIA (USA)
The AmeriDx® Calprotectin (CPTN) Rapid Test Kit is a qualitative test that detects CPTN antigen in human fecal specimens and other body ...
Manufactured by:Finch Therapeutics Group, Inc. based inSomerville, MASSACHUSETTS (USA)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes inflammation of the gastrointestinal (GI) ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
NS6180 is a new orally active KCa3.1 channel inhibitor. NS6180 inhibits cloned human KCa3.1 channels with an IC50value of 9 nM. NS6180 can be used for the research of inflammatory bowel disease (IBD) ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Glepaglutide (ZP1848), a long-acting GLP-2 analogue, is a potent GLP-2R agonist. Glepaglutide reduces faecal output and increases intestinal absorption. Glepaglutide alleviates small intestinal inflammation. Glepaglutide can be used in the research of inflammatory bowel disease (IBD) and Crohn’s ...
Manufactured by:JD Bioscience Inc. (JDB) based inBuk-gu, SOUTH KOREA
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory cytokines, such as IL-6 and TNF, produced by activated immune cells are suggested to drive the perpetuation of inflammation and tissue ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
TCJL37 is a potent, selective, and orally bioavailable TYK2 inhibitor with a Ki of 1.6 nM. TCJL37 can be used for the research of inflammatory bowel diseases ...
by:Genova Diagnostics based inAsheville,, NORTH CAROLINA (USA)
A Non-Invasive Stool Biomarker of Pancreatic Exocrine Function. Pancreatic elastase is a protein-digesting enzyme exclusively produced by the human pancreas, and serves as a non-invasive stool biomarker of pancreatic exocrine function. Pancreatic elastase measured in stool has a strong correlation with the invasive gold-standard test for pancreatic insufficiency and, therefore, is a ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
DC-SX029 is a potent SNX10 protein-protein interaction (PPI) inhibitor with oral activity with an estimated KD constant of ~0.935 μM by surface plasmon resonance (SPR). DC-SX029 blocks the SNX10-PIKfyve interaction, thereby decreased the TBK1/c-Rel signaling activation. DC-SX029 does not affect the protein level of SNX10. DC-SX029 has the potential for inflammatory bowel disease (IBD) ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
CCR6 antagonist 1 is a CCR6 antagonist that inhibits the CCL20/CCR6 axis. CCR6 antagonist 1 can be used in the research of autoimmune-mediated inflammatory diseases, such as inflammatory bowel diseases ...